30th Jul 2024 15:59
AstraZeneca PLC - Cambridge, England-based biopharmaceutical maker - Prices two tranches of eurobonds, raising a total of EUR1.40 billion for "general corporate purposes". Issues EUR650 million in fixed-rate notes with a coupon of 3.121% maturing in August 2030, and EUR750 million in fixed-rate notes with a coupon of 3.278% maturing in August 2033. The offering, by subsidiary AstraZeneca Finance LLC, is run by BNP Paribas, Goldman Sachs International, Morgan Stanley and Societe Genarale as joint book-running managers.
Current stock price: 12,259.34 pence, down 0.9% in London on Tuesday
12-month change: up 9.6%
By Tom Waite, Alliance News editor
Comments and questions to [email protected]
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Related Shares:
Astrazeneca